Risk communication in consultations about hormone therapy in the menopause:: concordance in risk assessment and framing due to the context

被引:8
|
作者
Hoffmann, M.
Hammar, M.
Kjellgren, K. I.
Lindh-Astrand, L.
Ahlner, J.
机构
[1] Linkoping Univ, Div Clin Pharmacol, Dept Med & Care, Fac Hlth Sci, Linkoping, Sweden
[2] Linkoping Univ, Dept Obstet & Gynecol, Dept Mol & Clin Med, Fac Hlth Sci, Linkoping, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Nursing, Fac Hlth & Caring Sci, Gothenburg, Sweden
[4] Nalt Board Forens Med, Dept Forens Chem, Linkoping, Sweden
关键词
risk; risk assessment; communication; physician-patient relations; professional-patient relations;
D O I
10.1080/13697130600870220
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background It is important for the physician and the patient to have a mutual understanding of the possible consequences of different treatment alternatives in order to achieve a partnership in decision-making. Objective The aim of this study was to explore to which degree first-time consultations for discussion of climacteric discomfort achieved shared understanding of the risks and benefits associated with hormone therapy in the menopausal transition. Methods Analysis of structure and content of transcribed consultations (n=20), and follow-up interviews of the women (n=19 pairs of consultations and interviews), from first-time visits for discussion of climacteric discomfort and/or HT with five physicians at three different outpatient clinics of gynecology in Sweden. Results Four distinctively different interpretations of risk, depending on whether or not benefits were discussed in the same context, emerged from the analysis. On average, five advantages (range 0-11) and two (0-3) disadvantages were mentioned during the consultations. In the interviews, the women expressed on average four advantages (0-7) and one disadvantage (0-3). There were major variations between advantages and disadvantages expressed in the consultation and the following interview. Conclusion Even though the consultations scored high in patient involvement, the information in most consultations was not structured in a way that made it possible to achieve a shared or an informed decision-taking.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 50 条
  • [31] Combined hormone therapy after menopause does not raise cervical cancer risk
    Hollander, D.
    INTERNATIONAL FAMILY PLANNING PERSPECTIVES, 2007, 33 (01): : 43 - 43
  • [32] Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation
    Corrao, G.
    Zambon, A.
    Conti, V.
    Nicotra, F.
    La Vecchia, C.
    Fornari, C.
    Cesana, G.
    Contier, P.
    Tagliabue, G.
    Nappi, R. E.
    Merlino, L.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 150 - 155
  • [33] Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
    Beral, Valerie
    Reeves, Gillian
    Bull, Diana
    Green, Jane
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (04): : 296 - 305
  • [34] Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
    Rossouw, Jacques E.
    Prentice, Ross L.
    Manson, Joann E.
    Wu, LieLing
    Barad, David
    Barnabei, Vanessa M.
    Ko, Marcia
    LaCroix, Andrea Z.
    Margolis, Karen L.
    Stefanick, Marcia L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (13): : 1465 - 1477
  • [35] Assessment of a visual risk communication aid used to support patients in deciding about biological therapy
    Dolan, M.
    O'Connor, R.
    Hellen, R.
    Rogers, S.
    Connolly, M.
    Tobin, A. -M.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 : 74 - 74
  • [36] Hormone therapy and breast cancer: risk communication and the "perfect storm'
    Reid, R. L.
    CLIMACTERIC, 2019, 22 (01) : 13 - 16
  • [37] Assessment of Risk Communication about Undercooked Hamburgers by Restaurant Servers
    Thomas, Ellen M.
    Binder, Andrew R.
    Mclaughlin, Anne
    Jaykus, Lee-Ann
    Hanson, Dana
    Powell, Douglas
    Chapman, Benjamin
    JOURNAL OF FOOD PROTECTION, 2016, 79 (12) : 2113 - 2118
  • [38] HORMONE-THERAPY DURING MENOPAUSE AND RISK OF BREAST-CANCER - QUESTIONS AND CONTROVERSIES
    SITRUKWARE, R
    PRESSE MEDICALE, 1994, 23 (01): : 38 - 42
  • [39] Menopause, hormone replacement therapy and cardiovascular risk. Biological bases and clinical evidence
    Simoncini, T.
    Genazzani, A. R.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2005, 27 (11-12): : 482 - 486
  • [40] Hormone replacement therapy for somatopause: risk-benefit analysis and precedents in the treatment of menopause
    Lamberts, SWJ
    GROWTH HORMONE & IGF RESEARCH, 2000, 10 : S52 - S53